NCT05027659

Brief Summary

The present study was conducted with 44 patients who applied to the Endoscopy Unit of a university hospital for sedation-free colonoscopy between January 2, 2020 and September 28, 2020, met the inclusion criteria and agreed to participate in the study. The patients were homogeneously divided into experimental (n=22) and control (n=22) groups based on their gender and history of colonoscopy. The patients in the experimental group watched a 360 degree virtual reailty (VR) video with atmospheric background music over images and sounds of nature through virtual reality glasses while no application was performed for the patients in the control group during the procedure. The "Demographic Information Form", "Trait Anxiety Scale", "Visual Analog Scale-Pain", "Visual Analog Scale-Anxiety", "Vital Signs Monitoring Chart" and "Satisfaction Evaluation on the Virtual Reality Glasses Application" forms were used in the data collection phase. For the study, an ethics committee approval was obtained in addition to written consent by the institutions and patients. Numbers, percentages, the Chi-square test, the Wilcoxon test and the Mann-Whitney U test were used for data analysis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 2, 2020

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 28, 2020

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2020

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

July 15, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 30, 2021

Completed
Last Updated

August 30, 2021

Status Verified

August 1, 2021

Enrollment Period

9 months

First QC Date

July 15, 2021

Last Update Submit

August 24, 2021

Conditions

Keywords

Anxietycolonoscopypainvirtual reality glassesvital signs

Outcome Measures

Primary Outcomes (6)

  • blood pressure

    mmHg. higher scores mean a worse

    Change in systolic blood pressure during colonoscopy, an average of 20 minutes

  • pulse rate (heart rate)

    beats per minute. higher scores mean a worse

    Change in pulse rate during colonoscopy, an average of 20 minutes

  • respiratory rate

    respiratory rate per minute. higher scores mean a worse

    Change in respiratory rate during colonoscopy, an average of 20 minutes

  • peripheral oxygen saturation (SpO2)

    Approaching 100% is considered positive. higher scores mean a better

    Change in peripheral oxygen saturation during colonoscopy, an average of 20 minutes

  • Pain score

    Visual Analog Scale-Pain (VAS-P), which is a 10cm long line with anchor statements "0=no pain" at the left-most end and "10=unbearable pain" at the right-most end. minimum=0, maximum=10; higher scores mean a worse and lower scores mean a better

    Change in pain score during colonoscopy, an average of 20 minutes

  • Anxiety score

    Visual Analog Scale-Anxiety (VAS-A), which is a 10 cm long horizontal line with anchor statements "0=no anxiety at all" at the left-most end and "10=worst anxiety imaginable" at the right-most end. minimum=0, maximum=10; higher scores mean a worse and lower scores mean a better

    Change in anxiety score during colonoscopy, an average of 20 minutes

Study Arms (2)

intervention

EXPERIMENTAL

This study was carried out with two groups. Virtual reality glasses were used for the intervention group.

Other: virtual reality glasses

control

NO INTERVENTION

No application was made to the control group, standard procedure was followed.

Interventions

Virtual reality (VR) glasses have a detachable screen frame compatible with smartphones. A VR headset has earphones and sensors that track the user's head movements, giving them the impression that they are moving around in a virtual environment. The investigators used a smartphone and VR glasses to perform the intervention. They connected the phone to the VR headset via a 360 degree VR video app. Experimental participants wore the VR glasses and watched a 360 degree VR video of nature scenes with ambiance music during colonoscopy. They put on the VR glasses right before the procedure and took them off right afterward.

intervention

Eligibility Criteria

Age18 Years - 79 Years
Sexall(Gender-based eligibility)
Gender Eligibility DetailsResearch shows that gender affect pain and anxiety during colonoscopy. Therefore, we randomized participants into the groups, which were similar in terms of gender.
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Voluntary
  • Scheduled for a colonoscopy without sedation
  • Aged 18 to 79 years
  • No perception, hearing, and vision impairment that interferes with communication
  • Not wearing glasses
  • No psychiatric disorder
  • No migraine, vertigo, active nausea, vomiting, headache, etc.

You may not qualify if:

  • no Voluntary
  • Scheduled for a colonoscopy with sedation
  • not been Aged 18 to 79 years
  • participants have been perception, hearing, and vision impairment that interferes with communication
  • wearing glasses
  • participants have psychiatric disorder
  • participants have migraine, vertigo, active nausea, vomiting, headache, etc.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kirikkale University

Kırıkkale, 71450, Turkey (Türkiye)

Location

Related Publications (1)

  • Dogan Yilmaz E, Unlusoy Dincer N. The Effects of Virtual Reality Glasses on Vital Signs and Anxiety in Patients Undergoing Colonoscopy: A Randomized Controlled Trial. Gastroenterol Nurs. 2023 Jul-Aug 01;46(4):318-328. doi: 10.1097/SGA.0000000000000733. Epub 2023 Jun 5.

MeSH Terms

Conditions

Anxiety DisordersPain

Condition Hierarchy (Ancestors)

Mental DisordersNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Esra DOĞAN YILMAZ RN, PhD, Research Assistant

    Kırıkkale University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The data of the study were entered by a person other than the researcher. Statistical analysis was performed by a person other than the researcher. In the study, virtual reality glasses were worn on the participants of experimental group. For this reason, blinding could not be done for the participants. The researcher herself collected all data because the hospital restricted traffic in and out of the unit due to the pandemic. Therefore, the evaluator was not blinded to the study.
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: A randomized controlled trial
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Research Assistant

Study Record Dates

First Submitted

July 15, 2021

First Posted

August 30, 2021

Study Start

January 2, 2020

Primary Completion

September 28, 2020

Study Completion

December 20, 2020

Last Updated

August 30, 2021

Record last verified: 2021-08

Data Sharing

IPD Sharing
Will not share

The confidentiality of the data used in the study will be protected.

Locations